Nicox S.A. (EPA:ALCOX)
0.4040
-0.0030 (-0.74%)
Apr 24, 2026, 4:53 PM CET
Nicox Market Cap
Nicox has a market cap or net worth of €35.87 million as of April 24, 2026. Its market cap has increased by 119.23% in one year.
Market Cap
35.87M
Enterprise Value
45.01M
Revenue
3.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.40
Market Cap Chart
Since November 3, 1999, Nicox's market cap has decreased from 260.94M to 35.87M, a decrease of -86.25%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 35.87M | 48.74% |
| Dec 31, 2025 | 24.12M | 24.81% |
| Dec 31, 2024 | 19.32M | -12.36% |
| Dec 29, 2023 | 22.05M | -60.51% |
| Dec 30, 2022 | 55.83M | -49.18% |
| Dec 31, 2021 | 109.84M | -31.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adocia | 92.79M |
| Valerio Therapeutics Société anonyme | 73.82M |
| OSE Immunotherapeutics | 68.25M |
| Fermentalg | 53.83M |
| THX Pharma Société Anonyme | 45.25M |
| genOway Société anonyme | 23.05M |
| Advicenne | 19.18M |
| GenSight Biologics | 19.11M |